160
Participants
Start Date
September 29, 2017
Primary Completion Date
November 15, 2018
Study Completion Date
February 25, 2019
Glecaprevir/Pibrentasvir
Coformulated tablet for oral administration
Seoul National Univ Bundang ho /ID# 163408, Seongnam
Inje University Busan Paik Hospital /ID# 163384, Pusan
Pusan Nat Univ Yangsan Hosp /ID# 163385, Yangsan
Beijing Di Tan Hospital, Capital Medical University /ID# 156852, Beijing
1st Hospital of Peking Uni /ID# 156850, Beijing
Peking University Peoples Hospit /ID# 156851, Beijing
Beijing Friendship Hospital /ID# 156843, Beijing
Beijing Youan Hosp, Cap Med Un /ID# 163418, Beijing
Shengjing Hospital of China Medical University /ID# 156829, Shenyang
The Sixth People's Hospital of Shenyang /ID# 156854, Shenyang
The First Hosp of Jilin Univ /ID# 156825, Changchun
Ruijin Hospital, Shanghai Jiaotong /ID# 157337, Shanghai
Huashan Hospital of Fudan University /ID# 156909, Shanghai
Shanghai Public Health Cli Ctr /ID# 156837, Shanghai
Chinese People's Liberation Army 81 Hospital /ID# 156868, Nanjing
The Second Hospital of Nanjing /ID# 156869, Nanjing
Jiangsu Province People's Hospital /ID# 156867, Nanjing
Mengchao Hepatobiliary Hospita /ID# 156907, Fuzhou
2nd Affiliated Hosp Chongqing /ID# 156838, Chongqing
Henan Provincial Peoples Hosp /ID# 157371, Zhengzhou, Henan
Guangzhou Eighth People's Hosp /ID# 156865, Guangzhou
Guangdong General Hospital /ID# 156827, Guangzhou
Nanfang Hospital of Southern Medical University /ID# 156866, Guangzhou
The Third Affiliated Hospital Of Sun Yat-Sen University /ID# 156905, Guangzhou
West China Hospital /ID# 156835, Chengdu
Fourth Military Medical University Tangdu Hospital, PLA /ID# 156767, Xi'an
First Affiliated Hospital of Medical College of Xi'an Jiaotong University /ID# 163420, Xi'an
1st Aff Hosp Xinjiang Med Uni /ID# 156891, Ürümqi
Pusan National University Hosp /ID# 163411, Busan
Severance Hospital /ID# 163399, Seoul
Samsung Medical Center /ID# 163402, Seoul
Korea University Guro Hospital /ID# 163412, Seoul
Seoul National University Hospital /ID# 163401, Seoul
Asan Medical Center /ID# 163398, Seoul
Lead Sponsor
AbbVie
INDUSTRY